As efforts to control health care costs intensify, alternate sites of care are playing a larger role in optimizing the delivery of services. This care migration coupled with a robust pipeline of novel injectable and IV-administered drugs put the home and specialty infusion therapy industry in an ideal position for substantial, prolonged growth.
It’s a prerequisite that companies looking to grow their market share in the fertile home and alternate site infusion industry reach the multi-disciplinary providers in this unique care model.
NHIA, the only national trade group serving this audience, has been deeply involved with this pioneering industry since its early days in the 1980s. Reach more than 12,000 industry professionals through key NHIA member communication channels.